Peripheral-blood versus bone marrow stem cells. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Peripheral-blood versus bone marrow stem cells.

Claudio Anasetti, Brent R Logan, Dennis L Confer, Blood and Marrow Transplant Clinical Trials Network

Author Information

PMID: 23323911 DOI: 10.1056/NEJMc1214025

No abstract text available.

Bone Marrow Diseases

Bone Marrow Transplantation

Female

Humans

Leukemia

Male

Peripheral Blood Stem Cell Transplantation

Unrelated Donors

Letter Comment

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy.Fully automated, clinical-grade bone marrow processing: a single-centre experience.Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study.Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.